Approval · Notice of Compliance 7952 · 2006

NOZINAN: Notice of Compliance 7952

Issued May 11, 2006

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 7952
Date: May 11, 2006
Company: Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Neuroleptic

Products in this notice

Brand	DIN	Status today
NOZINAN	01927655	Cancelled Post Market
NOZINAN	01927663	Cancelled Post Market
NOZINAN	01927671	Cancelled Post Market
NOZINAN	01927728	Cancelled Post Market
NOZINAN	01927698	Marketed

Medicinal ingredients

METHOTRIMEPRAZINE MALEATE 25 MG per TAB
METHOTRIMEPRAZINE MALEATE 50 MG per TAB
METHOTRIMEPRAZINE MALEATE 5 MG per TAB
METHOTRIMEPRAZINE HCL 5 MG per ML
METHOTRIMEPRAZINE HCL 25 MG per ML